In their letter Docci et al. agree that assessment of volume concentration of uroguanylin in patients on maintenance dialysis status is important in differentiating between these two therapy. Nephron 2000; 84: 206-210 disorders. They propose an algorithm that is primarily based a number of features that have not been described in Bartter's Findings suggesting a diagnosis of CSW should include syndrome: she was hyponatraemic, her serum potassium orthostatic changes in blood pressure and pulse, dry mucous concentration was only mildly reduced at 2.8 mM, and her membranes, and flat neck veins. A progressive decline in spontaneous urinary chloride concentration was unusually weight and negative fluid balance as determined by review low (67 mEq/day) for classical Bartter's syndrome. The of hospital flow sheets are particularly useful pieces of authors did not report on a long history of known hypokalaeevidence supportive of a declining ECF volume. Laboratory mia in their patient-as would be typical for Bartter's findings that are useful include evidence of haemoconcentrasyndrome-nor did they report measurements of urinary tion as reflected by an increased haematocrit and increased prostaglandins, the renal distal fractional chloride excretion serum albumin concentration. In many, if not most, instances rate, the results of platelet studies, the results of genetic such an evaluation is sufficient in determining the volume analyses (concerning the chloride and potassium transporters status of the patient. If after a thorough review of these of the TALH ) or a trial using indomethacin and its results. clinical parameters there is still ambiguity regarding the Therefore, it is by no means clear that the case presented volume status of the patient, only then should consideration truly has classical Bartter's syndrome. We propose that the be given to placing a central venous catheter for measurement diagnosis of 'Bartter's syndrome' be used in a more specific of CVP.
manner and on the basis of established literature. The second point is that measurement of CVP is most accurate in assessing volume status in the absence of cardiac Nephrologie Peter Gross and pulmonary disease [2, 3] . Unfortunately, such diseases Universitätsklinikum Carl Gustav are common in the general population. As a result CVP Carus measurements could be potentially misleading in a sizeable Dresden number of patients who present with disorders that are Germany associated with either CSW or SIADH.
In summary, because of the divergent nature of CSW and SIADH therapies, accurate assessment of ECF volume is of Reply critical importance in the approach to the hyponatraemic patient with underlying neurologic disease. Measurement of Sir, CVP can be a useful adjunct in assessing the volume status We thank very much Prof. Dr P. Gross for his letter and of patients with either CSW or SIADH. However, rather comment concerning our 'Case report'. The case we presented than being the initial step in this process, measurement of was a combination of hypokalaemia and metabolic alkalosis CVP should only be considered in patients without under-with vasculitis. We reviewed the literature because we had to lying pulmonary or cardiac disease and in whom less invasive make a differential diagnosis between Bartter's syndrome, clinical tools have failed to clarify the volume status. Gitelman syndrome, Bartter-like syndrome and Milk-Alkali Techniques that are currently being investigated to define syndrome. The patient satisfied most of the criteria of better the dry weight of chronic haemodialysis patients may Bartter's syndrome with hypokalaemia, metabolic alkalosis, eventually enable the clinician to define more objectively hyperreninemic hyperaldosteronism with normal serum magthe volume status of patients in everyday practice. Such nesium and disturbed concentrating urine capacity. We agree techniques include echocardiographic determination of the that it would be suitable for the diagnosis to measure urinary diameter of the inferior vena cava, bioelectric impedance prostaglandins and to make some additional examinations measurements and measuring the circulating levels of cyclic such as genetic analyses but unfortunately we have not the guanosine 3∞5∞-monophosphate and natriuretic peptides [4, 5] . possibility to perform them. A short course with indometh- 
